Scientists Search for 'Anti-Ozempic' to Prevent Cancer Cachexia
Scientists are researching ways to counteract cachexia, a wasting condition in cancer patients, by targeting biological pathways like interleukin-6, aiming to improve quality of life and survival rates, and develop an 'anti-Ozempic' approach to boost appetite and resilience in patients.